Related by context. Frequent words. (Click for all words.) 78 theSecurities 70 ExchangeCommission 65 Form 8K 65 SEC 'S WEBSITE 65 Form# K 65 'S WEB SITE 64 SECURITIES AND EXCHANGE COMMISSION 63 prospectus supplement dated 63 WWW.SEC.GOV 62 FILED WITH THE 62 www.sedar.com www.sedar.com 62 Shelf Registration Statement 62 Management Proxy Circular 62 Schedule #A filed 61 EXCHANGE COMMISSION 61 IMPORTANT INFORMATION 61 Prospectus dated 61 Definitive Proxy Statement 61 www.marketaxess.com 61 http:/www.sedar.com/ 61 Prospectus Supplement 61 Schedule #A 61 THE SECURITIES AND 61 Marches Financiers 60 JOINT PROXY STATEMENT PROSPECTUS 60 AT HTTP :/ 60 French Autorité des Marchés 60 8K filing 60 French Autorite des 60 -leukemias 60 definitive Proxy Statement 60 WHEN THEY BECOME AVAILABLE 59 Joint Proxy Statement Prospectus 59 Joint Proxy Statement 59 incorporated therein 59 filed Solicitation Recommendation 59 ARE URGED TO READ 59 BECAUSE THEY WILL CONTAIN 59 Filing Statement dated 58 Information Form AIF 58 AND OTHER DOCUMENTS FILED 58 DISCLOSURE NOTICE 58 ANY OTHER RELEVANT DOCUMENTS 58 audited Consolidated 58 Stockholders Approve 58 Files Registration Statement 58 RISK FACTORS 58 ANNUAL REPORT ON FORM 57 Webcast Annual Meeting 57 SEC EDGAR database 57 Final Prospectus 57 INVESTORS AND SECURITY HOLDERS 57 sedar.com 56 THEY BECOME AVAILABLE BECAUSE 56 THEY WILL CONTAIN IMPORTANT 56 Schedule #E 56 Gathering Analysis 56 http:/www.sedar.com 56 supplements thereto 56 Offering Circular 56 Q2 Loss Narrows 56 #Q filing 56 www.garmin.com aboutGarmin invRelations finReportsOshana Region 56 Sedar www.sedar.com 56 Declares Quarterly Dividends 56 Medtronic Annual Report 56 Extends Tender Offer 56 Announces Filing 56 CommScope filings 56 www.biosantepharma.com 56 IMPORTANT INFORMATION ABOUT 56 * Potentially libelous 56 Radware Form 56 Provides Guidance 56 Offer Documents 55 risks anduncertainties 55 Statements Certain 55 BECOME AVAILABLE BECAUSE THEY 55 READ THE PROXY 55 STOCKHOLDERS OF 55 Schedule TO 55 Form #KSB 55 Web site http:/www.EmergingStockReport.com 55 www.emergentbiosolutions.com 55 Form #Q 55 http:/www.diodes.com 55 site www.buyins.net 55 definitive proxy 55 INVESTORS ARE URGED TO 55 Exchange Commission 55 www.exelixis.com 55 www.crucell.com 55 AND ANY OTHER 55 SEC filings 54 THE JOINT PROXY 54 Schedule #D 9 54 ARE ADVISED TO READ 54 www.citigroup.com 54 prospectus proxy 54 Form #K 54 No. #-# [001]